JPMorgan Chase & Co. Lowers Colgate-Palmolive (NYSE:CL) Price Target to $95.00

Colgate-Palmolive (NYSE:CL) had its price target decreased by analysts at JPMorgan Chase & Co. from $99.00 to $95.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 1.07% from the stock’s current price.

Several other research firms also recently commented on CL. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Friday, April 4th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Morgan Stanley reduced their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. TD Cowen dropped their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, Raymond James reissued an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.67.

Colgate-Palmolive Trading Up 2.4 %

Shares of NYSE:CL opened at $93.99 on Friday. The business’s 50-day moving average is $90.48 and its 200 day moving average is $92.65. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The firm has a market capitalization of $76.24 billion, a P/E ratio of 26.70, a P/E/G ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company posted $0.87 earnings per share. On average, research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has approved a stock repurchase plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Chicago Partners Investment Group LLC increased its stake in Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after buying an additional 943 shares in the last quarter. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $1,315,000. Aviva PLC increased its position in shares of Colgate-Palmolive by 13.4% during the fourth quarter. Aviva PLC now owns 973,421 shares of the company’s stock worth $88,494,000 after purchasing an additional 114,855 shares in the last quarter. Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $4,066,000. Finally, Impact Partnership Wealth LLC purchased a new position in Colgate-Palmolive in the 4th quarter valued at $803,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.